Annual Accounts Receivable
$7.52 B
+$924.37 M+14.01%
31 December 2023
Summary:
GSK annual accounts receivable is currently $7.52 billion, with the most recent change of +$924.37 million (+14.01%) on 31 December 2023. During the last 3 years, it has fallen by -$907.47 million (-10.76%). GSK annual accounts receivable is now -31.14% below its all-time high of $10.92 billion, reached on 31 December 2007.GSK Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$9.88 B
+$698.82 M+7.61%
30 September 2024
Summary:
GSK quarterly accounts receivable is currently $9.88 billion, with the most recent change of +$698.82 million (+7.61%) on 30 September 2024. Over the past year, it has increased by +$2.36 billion (+31.34%). GSK quarterly accounts receivable is now -9.56% below its all-time high of $10.92 billion, reached on 31 December 2007.GSK Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +31.3% |
| 3 y3 years | -10.8% | +17.2% |
| 5 y5 years | +4.6% | +37.3% |
GSK Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -10.8% | +14.0% | -9.4% | +49.7% |
| 5 y | 5 years | -10.8% | +14.0% | -9.4% | +49.7% |
| alltime | all time | -31.1% | +1873.9% | -9.6% | +2492.5% |
GSK Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.88 B(+7.6%) |
| June 2024 | - | $9.18 B(+6.5%) |
| Mar 2024 | - | $8.62 B(+14.6%) |
| Dec 2023 | $7.52 B(+14.0%) | $7.52 B(-27.8%) |
| Sept 2023 | - | $10.42 B(+22.0%) |
| June 2023 | - | $8.55 B(+1.0%) |
| Mar 2023 | - | $8.46 B(+28.3%) |
| Dec 2022 | $6.60 B(-21.7%) | $6.60 B(-21.3%) |
| Sept 2022 | - | $8.38 B(+7.1%) |
| June 2022 | - | $7.83 B(-28.2%) |
| Mar 2022 | - | $10.90 B(+29.3%) |
| Dec 2021 | $8.43 B(+11.5%) | $8.43 B(-18.4%) |
| Sept 2021 | - | $10.33 B(+8.2%) |
| June 2021 | - | $9.55 B(+7.0%) |
| Mar 2021 | - | $8.92 B(+18.0%) |
| Dec 2020 | $7.56 B(+5.1%) | $7.56 B(-25.1%) |
| Sept 2020 | - | $10.10 B(+14.5%) |
| June 2020 | - | $8.82 B(-16.4%) |
| Mar 2020 | - | $10.55 B(+46.7%) |
| Dec 2019 | $7.19 B(+9.5%) | $7.19 B(-28.4%) |
| Sept 2019 | - | $10.05 B(+15.3%) |
| June 2019 | - | $8.71 B(+2.0%) |
| Mar 2019 | - | $8.54 B(+30.1%) |
| Dec 2018 | $6.57 B(+4.3%) | $6.57 B(-30.9%) |
| Sept 2018 | - | $9.50 B(+10.8%) |
| June 2018 | - | $8.58 B(+0.2%) |
| Mar 2018 | - | $8.56 B(+35.9%) |
| Dec 2017 | $6.30 B(+11.1%) | $6.30 B(-27.7%) |
| Sept 2017 | - | $8.72 B(+8.1%) |
| June 2017 | - | $8.06 B(+3.8%) |
| Mar 2017 | - | $7.77 B(+37.0%) |
| Dec 2016 | $5.67 B(+0.1%) | $5.67 B(-38.4%) |
| Sept 2016 | - | $9.20 B(+17.0%) |
| June 2016 | - | $7.87 B(-6.5%) |
| Mar 2016 | - | $8.41 B(+48.4%) |
| Dec 2015 | $5.67 B(+2.4%) | $5.67 B(-36.7%) |
| Sept 2015 | - | $8.95 B(+7.1%) |
| June 2015 | - | $8.36 B(+2.7%) |
| Mar 2015 | - | $8.14 B(+47.0%) |
| Dec 2014 | $5.53 B(-15.4%) | $5.53 B(-32.8%) |
| Sept 2014 | - | $8.24 B(-3.3%) |
| June 2014 | - | $8.52 B(-3.8%) |
| Mar 2014 | - | $8.86 B(+35.4%) |
| Dec 2013 | $6.54 B(-1.7%) | $6.54 B(-22.3%) |
| Sept 2013 | - | $8.42 B(-1.2%) |
| June 2013 | - | $8.52 B(-1.2%) |
| Mar 2013 | - | $8.62 B(+29.7%) |
| Dec 2012 | $6.65 B | $6.65 B(-27.0%) |
| Sept 2012 | - | $9.11 B(+6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $8.56 B(-6.7%) |
| Mar 2012 | - | $9.18 B(+34.1%) |
| Dec 2011 | $6.84 B(-6.2%) | $6.84 B(-25.5%) |
| Sept 2011 | - | $9.19 B(-2.0%) |
| June 2011 | - | $9.38 B(-1.9%) |
| Mar 2011 | - | $9.56 B(+31.0%) |
| Dec 2010 | $7.30 B(-30.5%) | $7.30 B(-22.8%) |
| Sept 2010 | - | $9.45 B(+5.2%) |
| June 2010 | - | $8.99 B(-13.1%) |
| Mar 2010 | - | $10.34 B(-1.5%) |
| Dec 2009 | $10.50 B(+14.4%) | $10.50 B(+8.5%) |
| Sept 2009 | - | $9.68 B(+9.6%) |
| June 2009 | - | $8.83 B(+4.0%) |
| Mar 2009 | - | $8.49 B(-7.4%) |
| Dec 2008 | $9.18 B(-16.0%) | $9.18 B(-6.1%) |
| Sept 2008 | - | $9.77 B(-9.1%) |
| June 2008 | - | $10.74 B(+1.9%) |
| Mar 2008 | - | $10.55 B(-3.5%) |
| Dec 2007 | $10.92 B(+28.1%) | $10.92 B(+6.2%) |
| Sept 2007 | - | $10.28 B(+1.2%) |
| June 2007 | - | $10.16 B(+0.8%) |
| Mar 2007 | - | $10.08 B(+18.2%) |
| Dec 2006 | $8.53 B(+12.5%) | $8.53 B(+501.0%) |
| Sept 2006 | - | $1.42 B(-84.6%) |
| June 2006 | - | $9.22 B(+21.6%) |
| Dec 2005 | $7.58 B(-11.2%) | $7.58 B(+951.1%) |
| Sept 2005 | - | $721.56 M(-1.0%) |
| June 2005 | - | $728.57 M(-7.7%) |
| Mar 2005 | - | $789.60 M(-90.8%) |
| Dec 2004 | $8.54 B(+28.7%) | $8.54 B(+7.3%) |
| Sept 2004 | - | $7.96 B(+20.0%) |
| Dec 2003 | $6.63 B(+17.1%) | $6.63 B(-34.4%) |
| Mar 2003 | - | $10.12 B(+78.5%) |
| Dec 2002 | $5.67 B(+7.6%) | $5.67 B(+7.6%) |
| Dec 2001 | $5.27 B(+5.9%) | $5.27 B(+5.9%) |
| Dec 2000 | $4.97 B(+83.0%) | $4.97 B(+83.0%) |
| Dec 1999 | $2.72 B(+1.9%) | $2.72 B(+1.9%) |
| Dec 1998 | $2.67 B(+19.9%) | $2.67 B(+19.9%) |
| Dec 1997 | $2.22 B(-9.2%) | $2.22 B(-9.2%) |
| Dec 1996 | $2.45 B(+9.4%) | $2.45 B(+75.2%) |
| Dec 1995 | $2.24 B(+60.1%) | - |
| June 1994 | $1.40 B(+1.2%) | $1.40 B(+1.2%) |
| June 1993 | $1.38 B(+1.0%) | $1.38 B(+1.0%) |
| June 1992 | $1.37 B(+28.7%) | $1.37 B(+28.7%) |
| June 1991 | $1.06 B(+15.7%) | $1.06 B(+15.7%) |
| June 1990 | $918.56 M(+42.1%) | $918.56 M(+42.1%) |
| June 1989 | $646.27 M(+10.3%) | $646.27 M(+10.3%) |
| June 1988 | $586.14 M(+22.6%) | $586.14 M(+22.6%) |
| June 1987 | $478.15 M(+25.5%) | $478.15 M(+25.5%) |
| June 1986 | $381.10 M | $381.10 M |
FAQ
- What is GSK annual accounts receivable?
- What is the all time high annual accounts receivable for GSK?
- What is GSK quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for GSK?
- What is GSK quarterly accounts receivable year-on-year change?
What is GSK annual accounts receivable?
The current annual accounts receivable of GSK is $7.52 B
What is the all time high annual accounts receivable for GSK?
GSK all-time high annual accounts receivable is $10.92 B
What is GSK quarterly accounts receivable?
The current quarterly accounts receivable of GSK is $9.88 B
What is the all time high quarterly accounts receivable for GSK?
GSK all-time high quarterly accounts receivable is $10.92 B
What is GSK quarterly accounts receivable year-on-year change?
Over the past year, GSK quarterly accounts receivable has changed by +$2.36 B (+31.34%)